PRIMARY STUDY

Cannabis use of patients with inflammatory bowel disease in Germany: a cross-sectional survey

Key Findings:  Among surveyed patients with inflammatory bowel disease (IBD) in Germany, 17.5% had used cannabis recreationally in the past, 2.9% were current recreational users. 4.1% reported any type of past cannabis use and 4.3% report current use for the treatment of IBD. Reported benefits include improved pain, sleep quality, and less worry, however, they reported lower quality of life and higher anxiety and depression.